GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 63 days ( 0 % )
Last Price $1.36 0 %
High/ Low $1.36 - $1.36 0%
Chg 7 Days N/A $1.36 $1.36
Chg 30 Days N/A $1.36 $1.36
Chg 12 mos -86.29 % $9.92 $1.36
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -28.97 % Width: 2,248.76 %
Pred. range - 3 mos $1.36 - $1.36 0 % - 0 %
Pred. range - 12 mos N/A - $5.55 -100.00 % - 307.80 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2023-09-05 - 64 days
Long MA avg 12 mos Buy 2023-11-30 - 4 days
Short/Long MA avg 12 mos Buy 2023-11-30 - 4 days
Pivot Short Sell 2023-12-04 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development ... BVXV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT